Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies-Reference-Cited by-同舟云学术

Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies

Published:2002-06 Issue:6 Volume:19 Page:451-456
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Bauer Hartwig Wilhelm,Rahlfs Volker W,Lauener Pierre A,Bleßmann Gabriela S.S

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference33 articles.

1. The challenge of urinary tract infections;Ascher,1980

2. Bauer HW, Kempel A, Carrascosa Nerger A, Lühr-Giernalczyk C. Orale Immuntherapie als Präventionsmaßnahme bei rez:idivierenden Harnwegsinfektionen; Kosten-Nutzen-Analyse. 3, Symposium Disease Management, 1996;7:34–43.

3. lmmunopharmacological investigation with orally administered immunostimulant OM-89 in the mouse. adv. in immunomodul;Fontanges,1988

4. Oral immunotherapy in paraplegic patients with chronic urinary tract infections; a double-blind, placebo-controlled trial;Hachen;J. Urol.,1990

5. Meta-analysis of screening and diagnostic tests;Hasselblad;Psychol. Bulletin,1995

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Insights into the Synthesis of Oligosaccharides from Escherichia coli: Review;Current Organic Chemistry;2024-07-18

2. Immunoactive Prophylaxis Protocol of Uncomplicated Recurrent Urinary Tract Infections in a Cohort of 1104 Women Treated with Uromune® Vaccine;Life;2024-04-02

3. Overactive bladder, inflammation and urinary tract infection: pathogenetic parallels;Urology reports (St. - Petersburg);2024-03-29

4. Uropathogenic Escherichia coli in urinary tract infections;Molecular Medical Microbiology;2024

5. Análisis de efectividad y costes sanitarios de la inmunoprofilaxis con autovacuna MV140, vacuna MV140 y tratamiento antibiótico continuado en la prevención de las infecciones urinarias recurrentes;Actas Urológicas Españolas;2023-01